ADMA Biologics, Inc. ADMA
13.19 USD +0.52 (+4.10%)
At closeNov 11, 2026, 7:26 PM EST
13.20 +0.01 +0.08%
After hours · Nov 11, 7:26 PM ET
12.60 Day range 13.28
7.21 52-week range 20.46
- YTD
- -27.69%
- 1 year
- -17.72%
ADMA revenue history
Revenue is income from the company’s ordinary business activities.
510,173,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 510,173,000 | 83,719,000 | 19.63% |
| FY 2024 | 2024-12-31 | 426,454,000 | 168,239,000 | 65.15% |
| FY 2023 | 2023-12-31 | 258,215,000 | 104,135,000 | 67.59% |
| FY 2022 | 2022-12-31 | 154,080,000 | 73,137,000 | 90.36% |
| FY 2021 | 2021-12-31 | 80,943,000 | 38,723,217 | 91.72% |
| FY 2020 | 2020-12-31 | 42,219,783 | 12,870,700 | 43.85% |
| FY 2019 | 2019-12-31 | 29,349,083 | 12,363,793 | 72.79% |
| FY 2018 | 2018-12-31 | 16,985,290 | -5,775,270 | -25.37% |
| FY 2017 | 2017-12-31 | 22,760,560 | 12,099,523 | 113.49% |
| FY 2016 | 2016-12-31 | 10,661,037 | 3,483,404 | 48.53% |
| FY 2015 | 2015-12-31 | 7,177,633 | 1,262,088 | 21.34% |
| FY 2014 | 2014-12-31 | 5,915,545 | 2,847,968 | 92.84% |
| FY 2013 | 2013-12-31 | 3,067,577 | 1,949,459 | 174.35% |
| FY 2012 | 2012-12-31 | 1,118,118 | 357,076 | 46.92% |
| FY 2011 | 2011-12-31 | 761,042 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:01:46.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.